Abstract:Abstract Glioma is an extremely aggressive malignant neoplasm of the central nervous system. MicroRNA (miRNA) are known to bind to specific target mRNA to regulate post-transcriptional gene expression and are, therefore, currently regarded as promising biomarkers for glioma diagnosis and prognosis. The aim of the present study was to examine the pathogenesis and potential molecular markers of glioma by comparing the differential expression of miRNA and mRNA between glioma tissue and peritumor brain tissue. We explored the impact of screened core miRNA and mRNA on cell proliferation, invasion, and migration of glioma. An miRNA expression profile dataset (GSE90603) and a transcriptome profile dataset (GSE90598) were downloaded from combined miRNA-mRNA microarray chips in the Gene Expression Omnibus (GEO) database. Overall, 59 differentially expressed miRNAs (DEMs) and 419 differentially expressed genes (DEGs) were identified using the R limma software package. FunRich software was used to predict DEM target genes and miRNA-gene pairs, and Perl software was used to find overlapping genes between DEGs and DEM target genes. There were 129 overlapping genes regulated by nine miRNAs between target genes of the DEMs and DEGs. The Chinese Glioma Genome Atlas(CGGA) was analyzed in order to identify miRNAs with diagnostic and prognostic significance. MiR-139-5p, miR-137, and miR-338-3p were validated to be significantly linked to prognosis in glioma patients. Finally, we validated that miR-139-5p affected glioma malignant biological behavior via targeting gamma-aminobutyric acid A receptor alpha 1(GABRA1) through rescue experiments. Low miR-139-5p expression was correlated with survival probability and World Health Organization (WHO) grade. MiR-139-5p overexpression inhibited cell proliferation, migration, and invasion of glioma in vitro. GABRA1 was identified as a functional downstream target of miR-139-5p. Decreased GABRA1 expression was related to similar biological roles as miR-139-5p overexpression while upregulation of GABRA1 effectively reversed the inhibition effects of miR-139-5p. These results demonstrate a novel axis for miR-139-5p/GABRA1 in glioma progression and provide potential prognostic predictors and therapeutic target for glioma patients.

The Emerging Role of Mir‐19 in Glioma

miR-19b-3p inhibits glioma progression via interacting with lncRNA HAGLR

A Predicted Mir-27A-mediated Network Identifies a Signature of Glioma.

miR-19a and miR-19b Overexpression in Gliomas

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

MiR-19 regulates the proliferation and invasion of glioma by RUNX3 via β-catenin/Tcf-4 signaling.

The Mir-92B Functions As a Potential Oncogene by Targeting on Smad3 in Glioblastomas

The Modulation of Mir-195-tgf-β/smad3 Pathway on Proliferation, Apoptosis and Invasion of Glioma Cells

The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.

Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1

Mir-221/222 Promote Malignant Progression of Glioma Through Activation of the Akt Pathway

Effects of Mir-99A on the Migration and Proliferation of Glioma Cells

H19 Functions As a Competing Endogenous RNA to Regulate EMT by Sponging Mir-130A-3p in Glioma.

miR-19a/b promote EMT and proliferation in glioma cells via SEPT7-AKT-NF-κB pathway

Microrna-19a Promotes Glioma Cell Growth By Repressing Lrig1

Inhibitory Effects of Knocking Down Microrna-19A and Microrna-19B on Glioma Cell Growth in Vitro

miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.

Mir-19 Is A Potential Clinical Biomarker For Gastrointestinal Malignancy: A Systematic Review And Meta-Analysis

MiR-19b and Mir-20A Suppress Apoptosis, Promote Proliferation and Induce Tumorigenicity of Multiple Myeloma Cells by Targeting PTEN.

miR-29a-5p Regulates the Proliferation, Invasion, and Migration of Gliomas by Targeting DHRS4

Long Non−Coding RNA H19 Regulates Glioma Cell Growth and Metastasis via miR-200a-Mediated CDK6 and ZEB1 Expression